Dyne Therapeutics Inc — Balance Sheet (NASDAQ:DYN) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 353.33 M425.66 M306.32 M165.08 M691.23 M Total liabilities 10.97 M57.47 M53.96 M73.79 M61.4 M Total equity 342.37 M368.2 M252.36 M91.29 M629.84 M Total liabilities & shareholders' equities 353.33 M425.66 M306.32 M165.08 M691.23 M Total debt ————— Net debt —————

新闻

Dyne Therapeutics财报即将公布:DMD申报时间表成焦点

Dyne Therapeutics earnings ahead: DMD filing timeline in focus

Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?

Dyne Therapeutics: 2026 Catalysts Point To Further Upside (NASDAQ:DYN)

Japan grants orphan drug status to Dyne’s DM1 treatment

Dyne Therapeutics, Inc. (DYN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dyne Therapeutics, Inc. (DYN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:DYN) 2026-01-14

Dyne Therapeutics任命Vikram Karnani为董事会成员

Dyne Therapeutics appoints Vikram Karnani to board of directors

Dyne Therapeutics完成扩大规模公开发行，筹集4.025亿美元

Dyne Therapeutics raises $402.5 million in upsized public offering

Daktronics, Photronics, Dave & Buster's Entertainment, GE Vernova And Other Big Stocks Moving Higher On Wednesday - Abivax (NASDAQ:ABVX), Braze (NASDAQ:BRZE)